Drula Rares, Ott Leonie Florence, Berindan-Neagoe Ioana, Pantel Klaus, Calin George A
Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 40015 Cluj-Napoca, Romania.
Cancers (Basel). 2020 Jul 22;12(8):2009. doi: 10.3390/cancers12082009.
Liquid biopsies have become a convenient tool in cancer diagnostics, real-time disease monitoring, and evaluation of residual disease. Yet, the information still encrypted in the variety of tumor-derived molecules identified in biofluids has proven difficult to decipher due to the technological limitations imposed by their biological nature. Such is the case of extracellular vesicle (EV) encapsulated ncRNAs, which have gained traction in recent years as biomarkers. Due to their resilience towards degrading factors they may act as suitable disease indicators. This review addresses the less described issues in this context. We present an overview of less investigated biofluids that can be used for EV isolation in addition to different isolation approaches to overcome the technical challenges these specimens harbor. Furthermore, we summarize the latest technological advances providing improvement to ncRNA detection and analysis. Thereby, this review summarizes the current state-of-the-art methodologies regarding EV and EV derived miRNA analysis and how they compare to current approaches.
液体活检已成为癌症诊断、疾病实时监测和残留疾病评估中的便捷工具。然而,由于生物流体中鉴定出的各种肿瘤衍生分子所具有的生物学特性带来的技术限制,其中仍加密的信息难以破译。细胞外囊泡(EV)包裹的非编码RNA(ncRNA)便是如此,近年来它们作为生物标志物受到关注。由于其对降解因素具有抗性,它们可能是合适的疾病指标。本综述探讨了这方面较少被描述的问题。我们概述了除不同分离方法外,可用于EV分离的较少研究的生物流体,以克服这些样本所带来的技术挑战。此外,我们总结了为ncRNA检测和分析带来改进的最新技术进展。因此,本综述总结了关于EV和EV衍生miRNA分析的当前最先进方法,以及它们与当前方法的比较情况。